Item 5.02 Departure of Directors or Certain Officers; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On May 12, 2021, at the 2021 Annual Meeting of Stockholders (“Annual Meeting”) of Maxar Technologies Inc. (“Company”), the Company’s stockholders, upon recommendation of the Company’s Board of Directors, approved an amendment to the Maxar Technologies Inc. 2019 Incentive Award Plan (“2019 Plan”) to increase by 2,000,000 shares the number of shares of the Company’s common stock available for issuance under the 2019 Plan (“Plan Amendment”). The Plan Amendment became effective upon approval by the stockholders.
A summary of the Plan Amendment is set forth in the Company’s definitive proxy statement on Schedule 14A filed with the U.S. Securities and Exchange Commission on April 1, 2021 (“Proxy Statement”). That summary and the foregoing description of the Plan Amendment are qualified in their entirety by reference to the full text of the Plan Amendment, which is filed as Exhibit 10.1 hereto and incorporated into this Item 5.02 by reference.
Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.
At the Annual Meeting on May 12, 2021, the Company’s stockholders, upon recommendation of the Company’s Board of Directors, approved the amendment and restatement of the Company’s Amended and Restated Certificate of Incorporation (“Second Amended and Restated Certificate of Incorporation”) to include a federal forum selection provision. The Second Amended and Restated Certificate of Incorporation, which was included as Appendix B to the Proxy Statement, became effective on May 12, 2021 upon filing with the Delaware Secretary of State.
The foregoing description is qualified in its entirety by reference to the full text of the Company’s Second Amended and Restated Certificate of Incorporation, which is attached hereto as Exhibit 3.1 and incorporated into this Item 5.03 by reference.
Item 5.07 Submission of Matters to a Vote of Security Holders.
On May 12, 2021, the Company held the Annual Meeting. The Company previously filed with the U.S. Securities and Exchange Commission a definitive proxy statement and related materials pertaining to the Annual Meeting, which describe in detail each of the five proposals submitted to stockholders at the Annual Meeting. The final results for the votes regarding each proposal are set forth below.
Proposal One: The Company’s stockholders elected each of the director nominees, each to serve for a one-year term expiring at the 2022 annual meeting of stockholders and until their respective successors are duly elected and qualified. The votes regarding this proposal were as follows:
| | | | | | | | |
Name of Nominee | | Shares Voted For | | Shares Voted Against | | Shares Abstained | | Broker Non-Votes |
Gen. Howell M. Estes III | | 29,819,244 | | 1,237,389 | | 46,107 | | 9,016,261 |
Nick S. Cyprus | | 30,806,683 | | 252,630 | | 43,427 | | 9,016,261 |
Roxanne J. Decyk | | 30,573,409 | | 470,906 | | 58,425 | | 9,016,261 |
Joanne O. Isham | | 30,813,698 | | 255,100 | | 33,942 | | 9,016,261 |
Daniel L. Jablonsky | | 30,916,635 | | 158,889 | | 27,216 | | 9,016,261 |
Gen. C. Robert Kehler | | 30,673,507 | | 390,042 | | 39,191 | | 9,016,261 |
Gilman Louie | | 30,922,981 | | 138,212 | | 41,547 | | 9,016,261 |
Dr. L. Roger Mason, Jr. | | 30,822,458 | | 240,420 | | 39,862 | | 9,016,261 |
Dr. Heather A. Wilson | | 30,945,809 | | 123,531 | | 33,400 | | 9,016,261 |
Eric J. Zahler | | 29,834,387 | | 1,224,154 | | 44,199 | | 9,016,261 |
Eddy Zervigon | | 29,999,397 | | 1,060,557 | | 42,786 | | 9,016,261 |
Proposal Two: The Company’s stockholders approved, on a non-binding advisory basis, the compensation of the Company’s named executive officers. The votes regarding this proposal were as follows:
| | | | | | |
Shares Voted For | | Shares Voted Against | | Shares Abstained | | Broker Non-Votes |
30,246,070 | | 691,567 | | 165,103 | | 9,016,261 |